Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry (eCOBRA)
Safety And Effectiveness Evaluation Of COBRA PzF™ Coronary Stent System: A French Observational Postmarketing Registry
Sponsor: AlpinARC
This observational or N/A phase trial investigates ACS - Acute Coronary Syndrome and Myocardial Infarction and is currently completed. AlpinARC leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Sep 2018 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 4 earlier versions
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
May 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AlpinARC
- CeloNova BioSciences, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aix, France , Annecy, France , Antony, France , Aubagne, France , Avignon, France , Bayonne, France , Brivé, France , Clermont, France , Grenoble, France , Haguenau, France and 8 more locations